DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

Abstract

Antibodies capable of neutralizing divergent influenza A viruses could form the basis of a universal vaccine. Here, from subjects enrolled in an H5N1 DNA/MIV-prime-boost influenza vaccine trial, we sorted hemagglutinin cross-reactive memory B cells and identified three antibody classes, each capable of neutralizing diverse subtypes of group 1 and group 2 influenza A viruses. Co-crystal structures with hemagglutinin revealed that each class utilized characteristic germline genes and convergent sequence motifs to recognize overlapping epitopes in the hemagglutinin stem. All six analyzed subjects had sequences from at least one multidonor class, and—in half the subjects—multidonor-class sequences were recovered from >40% of cross-reactive B cells. By contrast, these multidonor-class sequences were rare in published antibody datasets. Vaccination with a divergent hemagglutinin can thus increase the frequency of B cells encoding broad influenza A-neutralizing antibodies. We propose the sequence signature-quantified prevalence of these B cells as a metric to guide universal influenza A immunization strategies.

Authors:
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; more »; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; « less
Publication Date:
Research Org.:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID); USDOE Office of Science (SC), Basic Energy Sciences (BES)
Contributing Org.:
NISC Comparative Sequencing Program
OSTI Identifier:
1389087
Alternate Identifier(s):
OSTI ID: 1314264
Grant/Contract Number:  
HHSN261200800001E; W-31-109-Eng-38
Resource Type:
Published Article
Journal Name:
Cell
Additional Journal Information:
Journal Name: Cell Journal Volume: 166 Journal Issue: 3; Journal ID: ISSN 0092-8674
Publisher:
Elsevier
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES

Citation Formats

Joyce, M. Gordon, Wheatley, Adam K., Thomas, Paul V., Chuang, Gwo-Yu, Soto, Cinque, Bailer, Robert T., Druz, Aliaksandr, Georgiev, Ivelin S., Gillespie, Rebecca A., Kanekiyo, Masaru, Kong, Wing-Pui, Leung, Kwanyee, Narpala, Sandeep N., Prabhakaran, Madhu S., Yang, Eun Sung, Zhang, Baoshan, Zhang, Yi, Asokan, Mangaiarkarasi, Boyington, Jeffrey C., Bylund, Tatsiana, Darko, Sam, Lees, Christopher R., Ransier, Amy, Shen, Chen-Hsiang, Wang, Lingshu, Whittle, James R., Wu, Xueling, Yassine, Hadi M., Santos, Celia, Matsuoka, Yumiko, Tsybovsky, Yaroslav, Baxa, Ulrich, Mullikin, James C., Subbarao, Kanta, Douek, Daniel C., Graham, Barney S., Koup, Richard A., Ledgerwood, Julie E., Roederer, Mario, Shapiro, Lawrence, Kwong, Peter D., Mascola, John R., and McDermott, Adrian B.. Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses. United States: N. p., 2016. Web. doi:10.1016/j.cell.2016.06.043.
Joyce, M. Gordon, Wheatley, Adam K., Thomas, Paul V., Chuang, Gwo-Yu, Soto, Cinque, Bailer, Robert T., Druz, Aliaksandr, Georgiev, Ivelin S., Gillespie, Rebecca A., Kanekiyo, Masaru, Kong, Wing-Pui, Leung, Kwanyee, Narpala, Sandeep N., Prabhakaran, Madhu S., Yang, Eun Sung, Zhang, Baoshan, Zhang, Yi, Asokan, Mangaiarkarasi, Boyington, Jeffrey C., Bylund, Tatsiana, Darko, Sam, Lees, Christopher R., Ransier, Amy, Shen, Chen-Hsiang, Wang, Lingshu, Whittle, James R., Wu, Xueling, Yassine, Hadi M., Santos, Celia, Matsuoka, Yumiko, Tsybovsky, Yaroslav, Baxa, Ulrich, Mullikin, James C., Subbarao, Kanta, Douek, Daniel C., Graham, Barney S., Koup, Richard A., Ledgerwood, Julie E., Roederer, Mario, Shapiro, Lawrence, Kwong, Peter D., Mascola, John R., & McDermott, Adrian B.. Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses. United States. https://doi.org/10.1016/j.cell.2016.06.043
Joyce, M. Gordon, Wheatley, Adam K., Thomas, Paul V., Chuang, Gwo-Yu, Soto, Cinque, Bailer, Robert T., Druz, Aliaksandr, Georgiev, Ivelin S., Gillespie, Rebecca A., Kanekiyo, Masaru, Kong, Wing-Pui, Leung, Kwanyee, Narpala, Sandeep N., Prabhakaran, Madhu S., Yang, Eun Sung, Zhang, Baoshan, Zhang, Yi, Asokan, Mangaiarkarasi, Boyington, Jeffrey C., Bylund, Tatsiana, Darko, Sam, Lees, Christopher R., Ransier, Amy, Shen, Chen-Hsiang, Wang, Lingshu, Whittle, James R., Wu, Xueling, Yassine, Hadi M., Santos, Celia, Matsuoka, Yumiko, Tsybovsky, Yaroslav, Baxa, Ulrich, Mullikin, James C., Subbarao, Kanta, Douek, Daniel C., Graham, Barney S., Koup, Richard A., Ledgerwood, Julie E., Roederer, Mario, Shapiro, Lawrence, Kwong, Peter D., Mascola, John R., and McDermott, Adrian B.. Thu . "Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses". United States. https://doi.org/10.1016/j.cell.2016.06.043.
@article{osti_1389087,
title = {Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses},
author = {Joyce, M. Gordon and Wheatley, Adam K. and Thomas, Paul V. and Chuang, Gwo-Yu and Soto, Cinque and Bailer, Robert T. and Druz, Aliaksandr and Georgiev, Ivelin S. and Gillespie, Rebecca A. and Kanekiyo, Masaru and Kong, Wing-Pui and Leung, Kwanyee and Narpala, Sandeep N. and Prabhakaran, Madhu S. and Yang, Eun Sung and Zhang, Baoshan and Zhang, Yi and Asokan, Mangaiarkarasi and Boyington, Jeffrey C. and Bylund, Tatsiana and Darko, Sam and Lees, Christopher R. and Ransier, Amy and Shen, Chen-Hsiang and Wang, Lingshu and Whittle, James R. and Wu, Xueling and Yassine, Hadi M. and Santos, Celia and Matsuoka, Yumiko and Tsybovsky, Yaroslav and Baxa, Ulrich and Mullikin, James C. and Subbarao, Kanta and Douek, Daniel C. and Graham, Barney S. and Koup, Richard A. and Ledgerwood, Julie E. and Roederer, Mario and Shapiro, Lawrence and Kwong, Peter D. and Mascola, John R. and McDermott, Adrian B.},
abstractNote = {Antibodies capable of neutralizing divergent influenza A viruses could form the basis of a universal vaccine. Here, from subjects enrolled in an H5N1 DNA/MIV-prime-boost influenza vaccine trial, we sorted hemagglutinin cross-reactive memory B cells and identified three antibody classes, each capable of neutralizing diverse subtypes of group 1 and group 2 influenza A viruses. Co-crystal structures with hemagglutinin revealed that each class utilized characteristic germline genes and convergent sequence motifs to recognize overlapping epitopes in the hemagglutinin stem. All six analyzed subjects had sequences from at least one multidonor class, and—in half the subjects—multidonor-class sequences were recovered from >40% of cross-reactive B cells. By contrast, these multidonor-class sequences were rare in published antibody datasets. Vaccination with a divergent hemagglutinin can thus increase the frequency of B cells encoding broad influenza A-neutralizing antibodies. We propose the sequence signature-quantified prevalence of these B cells as a metric to guide universal influenza A immunization strategies.},
doi = {10.1016/j.cell.2016.06.043},
journal = {Cell},
number = 3,
volume = 166,
place = {United States},
year = {2016},
month = {7}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record
https://doi.org/10.1016/j.cell.2016.06.043

Citation Metrics:
Cited by: 204 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120
journal, February 2004

  • Huang, C. -c.; Venturi, M.; Majeed, S.
  • Proceedings of the National Academy of Sciences, Vol. 101, Issue 9
  • DOI: 10.1073/pnas.0308527100

Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice
journal, June 2015


An In Vivo Human-Plasmablast Enrichment Technique Allows Rapid Identification of Therapeutic Influenza A Antibodies
journal, July 2013


Protection from the 2009 H1N1 Pandemic Influenza by an Antibody from Combinatorial Survivor-Based Libraries
journal, July 2010


Lineage Structure of the Human Antibody Repertoire in Response to Influenza Vaccination
journal, February 2013


Rapid development of broadly influenza neutralizing antibodies through redundant mutations
journal, October 2014

  • Pappas, Leontios; Foglierini, Mathilde; Piccoli, Luca
  • Nature, Vol. 516, Issue 7531
  • DOI: 10.1038/nature13764

Flow Cytometry Reveals that H5N1 Vaccination Elicits Cross-Reactive Stem-Directed Antibodies from Multiple Ig Heavy-Chain Lineages
journal, February 2014

  • Whittle, J. R. R.; Wheatley, A. K.; Wu, L.
  • Journal of Virology, Vol. 88, Issue 8
  • DOI: 10.1128/JVI.03422-13

Structural and genetic basis for development of broadly neutralizing influenza antibodies
journal, August 2012

  • Lingwood, Daniel; McTamney, Patrick M.; Yassine, Hadi M.
  • Nature, Vol. 489, Issue 7417
  • DOI: 10.1038/nature11371

Delineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization
journal, May 2013


Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells
journal, May 2012

  • Li, G. -M.; Chiu, C.; Wrammert, J.
  • Proceedings of the National Academy of Sciences, Vol. 109, Issue 23
  • DOI: 10.1073/pnas.1118979109

H7N9 Avian Influenza A Virus and the Perpetual Challenge of Potential Human Pandemicity
journal, July 2013

  • Morens, David M.; Taubenberger, Jeffery K.; Fauci, Anthony S.
  • mBio, Vol. 4, Issue 4
  • DOI: 10.1128/mBio.00445-13

A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
journal, August 2015


Human Infection with an Avian H9N2 Influenza A Virus in Hong Kong in 2003
journal, November 2005


Viral Receptor-Binding Site Antibodies with Diverse Germline Origins
journal, May 2015


Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming Effect
journal, April 2013

  • Ledgerwood, Julie E.; Zephir, Kathryn; Hu, Zonghui
  • The Journal of Infectious Diseases, Vol. 208, Issue 3
  • DOI: 10.1093/infdis/jit180

A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
journal, July 2011


DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
journal, December 2011


Antibody Recognition of a Highly Conserved Influenza Virus Epitope
journal, April 2009


Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
journal, February 2009

  • Sui, Jianhua; Hwang, William C.; Perez, Sandra
  • Nature Structural & Molecular Biology, Vol. 16, Issue 3
  • DOI: 10.1038/nsmb.1566

Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
journal, December 2015

  • Gorman, Jason; Soto, Cinque; Yang, Max M.
  • Nature Structural & Molecular Biology, Vol. 23, Issue 1
  • DOI: 10.1038/nsmb.3144

Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
journal, September 2012


Measurement and Clinical Monitoring of Human Lymphocyte Clonality by Massively Parallel V-D-J Pyrosequencing
journal, December 2009


Highly Conserved Protective Epitopes on Influenza B Viruses
journal, August 2012


A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
journal, July 2011


Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
journal, August 2015

  • Yassine, Hadi M.; Boyington, Jeffrey C.; McTamney, Patrick M.
  • Nature Medicine, Vol. 21, Issue 9
  • DOI: 10.1038/nm.3927

A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus
journal, July 2015

  • Wu, Ying; Cho, MyungSam; Shore, David
  • Nature Communications, Vol. 6, Issue 1
  • DOI: 10.1038/ncomms8708

Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells
journal, December 2008


In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire
journal, December 2014

  • DeKosky, Brandon J.; Kojima, Takaaki; Rodin, Alexa
  • Nature Medicine, Vol. 21, Issue 1
  • DOI: 10.1038/nm.3743

H5N1 Vaccine–Elicited Memory B Cells Are Genetically Constrained by the IGHV Locus in the Recognition of a Neutralizing Epitope in the Hemagglutinin Stem
journal, June 2015

  • Wheatley, Adam K.; Whittle, James R. R.; Lingwood, Daniel
  • The Journal of Immunology, Vol. 195, Issue 2
  • DOI: 10.4049/jimmunol.1402835

Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen
journal, June 2015


Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin
journal, August 2011

  • Whittle, J. R. R.; Zhang, R.; Khurana, S.
  • Proceedings of the National Academy of Sciences, Vol. 108, Issue 34
  • DOI: 10.1073/pnas.1111497108

Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes
journal, July 2016